UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 218

Sortiert nach

Metagenome Data on Intestinal Phage-Bacteria Associations Aids the Development of Phage Therapy against Pathobionts

Cell host & microbe, 2020-09, Vol.28 (3), p.380-389.e9

2020

Volltextzugriff (PDF)

Oral MucoRice-CTB vaccine is safe and immunogenic in healthy US adults

Vaccine, 2022-05, Vol.40 (24), p.3372-3379

2022

Volltextzugriff (PDF)

Arterial systolic and diastolic blood pressure are not associated with HbA1c levels but arterial systolic blood pressure alone associated with 1-h postchallenge glucose levels

International journal of diabetes in developing countries, 2022-10, Vol.42 (4), p.791-793

2022

Volltextzugriff (PDF)

Comparative whole-genome and proteomics analyses of the next seed bank and the original master seed bank of MucoRice-CTB 51A line, a rice-based oral cholera vaccine

BMC genomics, 2021-01, Vol.22 (1), p.59-12, Article 59

2021

Volltextzugriff (PDF)

MucoRice-CTB line 19A, a new marker-free transgenic rice-based cholera vaccine produced in an LED-based hydroponic system

Frontiers in plant science, 2024, Vol.15, p.1342662-1342662

2024

Volltextzugriff (PDF)

Seed Metabolome Analysis of a Transgenic Rice Line Expressing Cholera Toxin B-subunit

Scientific reports, 2017-07, Vol.7 (1), p.5196-11, Article 5196

2017

Volltextzugriff (PDF)

Outcome of glucose tolerance condition in patients with normal glucose tolerance with either persistently high or low 1-h postchallenge glucose levels in 75 g oral glucose tolerance test

International journal of diabetes in developing countries, 2022-10, Vol.42 (4), p.652-656

2022

Volltextzugriff (PDF)

Oral MucoRice-CTB vaccine for safety and microbiota-dependent immunogenicity in humans: a phase 1 randomised trial

The Lancet. Microbe, 2021-09, Vol.2 (9), p.e429-e440

2021

Volltextzugriff (PDF)

Induction of toxin‐specific neutralizing immunity by molecularly uniform rice‐based oral cholera toxin B subunit vaccine without plant‐associated sugar modification

Plant biotechnology journal, 2013-09, Vol.11 (7), p.799-808

2013

Volltextzugriff (PDF)

Hepatopulmonary Syndrome Caused by Congenital Portosystemic Shunt with Interstitial Pneumonia

Nihon Naika Gakkai Zasshi, 2021/06/10, Vol.110(6), pp.1163-1169

2021

Volltextzugriff (PDF)

Comparison of Material-Related Complications After Bilateral Sagittal Split Mandibular Setback Surgery: Biodegradable Versus Titanium Miniplates

Journal of oral and maxillofacial surgery, 2012-04, Vol.70 (4), p.919-924

2012

Volltextzugriff (PDF)

422-P: GLP-1 RA Should Be Used with SGLT2 Inhibitor in People with Rapidly Progressive CKD

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

Determination of genomic location and structure of the transgenes in marker-free rice-based cholera vaccine by using whole genome resequencing approach

Plant cell, tissue and organ culture, 2015-01, Vol.120 (1), p.35-48

2015

Volltextzugriff (PDF)

878-P: Maximize Benefits of SGLT2 Inhibitors in People with Advanced CKD Stages with Type 2 Diabetes

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

755-P: Liraglutide plus Basal Insulin Combination Therapy in Japanese Old-Aged People with Type 2 Diabetes: Peak Age at 70s

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

787-P: Individualized Estimated GFR Slope Analysis Is Needed to Preserve Renal Function by SGLT2 Inhibitors in Patients with DKD

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

402-P: Liraglutide Might Have Synergistic Renal Protection Effect with SGLT2 Inhibitors in Rapidly Progressive Diabetic Kidney Disease

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

1122-P: Sodium–Glucose Transporter 2 Inhibitor Delays Progression of Diabetic Kidney Disease in Japanese Patients with Type 2 Diabetes: Retrospective Slope Analysis of Renal Function

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

504-P: Albuminuria Affects Prevention of Diabetic Kidney Disease Progression by Sodium–Glucose Transporter 2 Inhibitor

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

2299-PUB: Liraglutide-Based Therapy Attained A1C Target with Little Risk of Hypoglycemia: Optimization by Average Daily Risk Range Measurement

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

Liraglutide-Based Therapy Shows More Prominent Effect than Conventional Insulin Therapy to Achieve HbA1c Target, Especially in Patients with Short Duration

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Volltextzugriff (PDF)

Short Duration of Diabetes Should Be Associated with More Prominent Effect of Liraglutide—Titrated from Insulin Degludec plus Liraglutide Combination Therapy

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Volltextzugriff (PDF)

Aging affects FIB-4 index in the general population without pre-existing diseases: Analysis of a cohort of healthy individuals who underwent annual health checkups for 10 consecutive years

Clinics and research in hepatology and gastroenterology, 2023-01, Vol.47 (1), p.102058-102058, Article 102058

2023

Volltextzugriff (PDF)

Oral tonsil in the floor of mouth: Ectopic oral tonsillar tissue simulating benign neoplasms

Oral science international, 2012-05, Vol.9 (1), p.29-31

2012

Volltextzugriff (PDF)

Mos and the mitogen-activated protein kinase do not show cytostatic factor activity in early mouse embryos

Journal of Reproduction and Development, 2007, Vol.53(6), pp.1175-1182

2007

Volltextzugriff (PDF)

1 – 25 von 218

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(183)
Mit Volltextzugriff
(197)

Publikationsform

Sprache

Englisch
(202)
Japanisch
(76)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Metagenome Data on Intestinal Phage-Bacteria Associations Aids the Development of Phage Therapy against Pathobionts

Oral MucoRice-CTB vaccine is safe and immunogenic in healthy US adults

Arterial systolic and diastolic blood pressure are not associated with HbA1c levels but arterial systolic blood pressure alone associated with 1-h postchallenge glucose levels

Comparative whole-genome and proteomics analyses of the next seed bank and the original master seed bank of MucoRice-CTB 51A line, a rice-based oral cholera vaccine

MucoRice-CTB line 19A, a new marker-free transgenic rice-based cholera vaccine produced in an LED-based hydroponic system

Seed Metabolome Analysis of a Transgenic Rice Line Expressing Cholera Toxin B-subunit

Outcome of glucose tolerance condition in patients with normal glucose tolerance with either persistently high or low 1-h postchallenge glucose levels in 75 g oral glucose tolerance test

Oral MucoRice-CTB vaccine for safety and microbiota-dependent immunogenicity in humans: a phase 1 randomised trial

Induction of toxin‐specific neutralizing immunity by molecularly uniform rice‐based oral cholera toxin B subunit vaccine without plant‐associated sugar modification

Hepatopulmonary Syndrome Caused by Congenital Portosystemic Shunt with Interstitial Pneumonia

Comparison of Material-Related Complications After Bilateral Sagittal Split Mandibular Setback Surgery: Biodegradable Versus Titanium Miniplates

422-P: GLP-1 RA Should Be Used with SGLT2 Inhibitor in People with Rapidly Progressive CKD

Determination of genomic location and structure of the transgenes in marker-free rice-based cholera vaccine by using whole genome resequencing approach

878-P: Maximize Benefits of SGLT2 Inhibitors in People with Advanced CKD Stages with Type 2 Diabetes

755-P: Liraglutide plus Basal Insulin Combination Therapy in Japanese Old-Aged People with Type 2 Diabetes: Peak Age at 70s

787-P: Individualized Estimated GFR Slope Analysis Is Needed to Preserve Renal Function by SGLT2 Inhibitors in Patients with DKD

402-P: Liraglutide Might Have Synergistic Renal Protection Effect with SGLT2 Inhibitors in Rapidly Progressive Diabetic Kidney Disease

1122-P: Sodium–Glucose Transporter 2 Inhibitor Delays Progression of Diabetic Kidney Disease in Japanese Patients with Type 2 Diabetes: Retrospective Slope Analysis of Renal Function

504-P: Albuminuria Affects Prevention of Diabetic Kidney Disease Progression by Sodium–Glucose Transporter 2 Inhibitor

2299-PUB: Liraglutide-Based Therapy Attained A1C Target with Little Risk of Hypoglycemia: Optimization by Average Daily Risk Range Measurement

Liraglutide-Based Therapy Shows More Prominent Effect than Conventional Insulin Therapy to Achieve HbA1c Target, Especially in Patients with Short Duration

Short Duration of Diabetes Should Be Associated with More Prominent Effect of Liraglutide—Titrated from Insulin Degludec plus Liraglutide Combination Therapy

Aging affects FIB-4 index in the general population without pre-existing diseases: Analysis of a cohort of healthy individuals who underwent annual health checkups for 10 consecutive years

Oral tonsil in the floor of mouth: Ectopic oral tonsillar tissue simulating benign neoplasms

Mos and the mitogen-activated protein kinase do not show cytostatic factor activity in early mouse embryos

Suchergebnisse filtern